Mentzer S J, Reilly J J, Caplan A L, Sugarbaker D J
Brigham Lung Transplant Program, Brigham and Women's Hospital, Boston, Mass. 02115.
J Heart Lung Transplant. 1994 Jan-Feb;13(1 Pt 1):56-8.
The decreased survival of patients undergoing lung retransplantation has raised ethical concerns regarding the "fairness" of using organs for retransplantation. This emphasis on organ utility could have important consequences for the doctor-patient relationship and the practice of retransplantation. In an attempt to balance the responsibilities of individual physicians toward their patients and the responsibilities of transplantation programs toward the public resource of donated organs, we propose a limit on the percentage of organs used for experimental or innovative procedures such as retransplantation. This limit would allow the physician to function as the patient advocate, ensure that organs are realistically allocated to patients most likely to benefit from transplantation, and permit an evolving definition of the medical efficacy of retransplantation.
肺再次移植患者生存率的降低引发了关于将器官用于再次移植“公平性”的伦理担忧。这种对器官效用的强调可能会对医患关系和再次移植的实践产生重要影响。为了平衡个体医生对患者的责任与移植项目对捐赠器官这一公共资源的责任,我们提议对用于诸如再次移植等实验性或创新性手术的器官比例加以限制。这一限制将使医生能够充当患者的支持者,确保器官切实分配给最有可能从移植中受益的患者,并允许对再次移植的医疗效果进行不断演变的定义。